Collectively, these findings demonstrate that Nfatc1 isoform 5 is preferentially expressed in DM CLL cells, whereas isoform 2 predominates in Mdr MT CLL cells. The gene discussed is NFATC1; the disease is B-cell chronic lymphocytic leukemia.